# Medison Ventures

Medison Ventures is a Venture Capital based in Petah Tikva, Israel.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Petah Tikva, Israel
- **Region:** Middle East
- **Address:** Petah Tikva, Israel
- **Assets under management:** Undisclosed
- **Website:** www.medisonventures.com
- **LinkedIn:** https://www.linkedin.com/company/medison

## Regulatory record

- **Reports private funds:** No

## About

Medison Ventures is a venture capital investment company based in Petah Tikva, Israel. It has 600 staff, with 10 investment professionals. The firm focuses on venture capital investments.

## Sectors

- Biotechnology
- Pharmaceuticals
- Healthcare Services
- Digital Health

## People

- Meir Jakobsohn — Founder

## Questions

### How does Medison Ventures' pharmaceutical operating background influence its investment decisions?

The firm leverages its parent company's experience in multi-country drug commercialization to evaluate portfolio companies on more than just scientific merit. Medison Pharma has built a track record of bringing therapies from global innovators like Biogen into markets that those companies cannot reach directly. This gives the venture team operational-grade diligence capabilities when assessing a startup's regulatory strategy, reimbursement pathway, and eventual commercial launch challenges.

### Does Medison Ventures invest only in Israeli companies?

While the firm has a primary geographic focus on Israeli-founded life sciences companies—reflecting the country's density of drug development innovation—Medison Ventures also evaluates opportunities in North America and Europe. The investment lens prioritizes firms where the parent entity's commercialization network or regulatory expertise can add strategic value beyond capital.

### Who runs investment decisions at Medison Ventures?

Founder Meir Jakobsohn, who serves as Executive Chairman of both Medison Pharma and Medison Ventures, anchors the investment function. The firm operates with a lean team model, drawing on the broader Medison Pharma executive network for technical and commercial diligence. Specific day-to-day investment committee composition has not been publicly disclosed.

## Related profiles

- [Mediqventures](https://altss.com/profile/mediqventures)
- [Mediterra Capital](https://altss.com/profile/mediterra-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/medison-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology